Lowell Farms to Announce First Quarter Financial Results
Cannabis industry leader to hold conference call on May 5SALINAS, Calif., April 21, 2021 (GLOBE NEWSWIRE) -- Lowell Farms (CSE:LOWL;...
Month: April 2021
NexImmune Appoints Chad Rubin as Senior Vice President, Corporate Affairs
Mr. Rubin most recently served as Managing Director, Co-Head Life Sciences for Solebury TroutGAITHERSBURG, Md., April 21, 2021 (GLOBE NEWSWIRE)...
Cyclerion Therapeutics to Participate in the B. Riley Neuroscience Investor Conference
CAMBRIDGE, Mass., April 21, 2021 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company on a mission...
Virtual End-to-End Care in Workers’ Compensation to be Presented at RIMS
CorVel Session Looks at How the Pandemic Pushed Transformation of Care, Next StepsIRVINE, Calif., April 21, 2021 (GLOBE NEWSWIRE) --...
Top Scarless Robotic Thyroid Surgery Center Led By Surgeon Dr Hyun Suh Opened
North America’s leading Thyroid Surgery Center has established the Suh Scarless Thyroid Surgery Center in Tampa Florida, to provide the...
Jushi Holdings Inc. Announces Certain Unaudited 2020 Fourth Quarter and Full Year 2020 Financial Results and Advises on Timing of Filing Annual Audited Financial Statements and Management’s Discussion and Analysis
--Fourth Quarter 2020 Revenue Increased 30% Sequentially to Revenue of $32.3 million; Gross Profit Increased 44% Sequentially to $17.6 million; Announces First...
Cerevel Therapeutics Appoints Abraham N. Ceesay as President
CAMBRIDGE, Mass., April 21, 2021 (GLOBE NEWSWIRE) -- Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain...
Tonix Pharmaceuticals to Participate in Fourth Annual Neuroscience Innovation Forum
CHATHAM, N.J., April 21, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) a clinical-stage...
Apellis Pharmaceuticals to Hold First Quarter 2021 Earnings Conference Call on April 28, 2021
WALTHAM, Mass., April 21, 2021 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in targeted...
Athira Pharma to Participate in Panel Discussion at Sachs 4th Annual Neuroscience Innovation Forum
BOTHELL, Wash., April 21, 2021 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing...
Khondrion announces first patients dosed in 6-month paediatric Phase II study of sonlicromanol for mitochondrial diseases
Khondrion announces first patients dosed in 6-month paediatric Phase II study of sonlicromanol for mitochondrial diseases Study will examine the...
Revolution Medicines Announces Dosing of First Patient in Phase 1/1b Clinical Study of RMC-5552 in Patients with Advanced Solid Tumors
First-in-Class Bi-steric mTORC1 Inhibitor Advances into Clinical Development Newly Issued U.S. Patent Further Strengthens RMC-5552 IP Portfolio REDWOOD CITY, Calif.,...
Retrotope Announces Completion of Enrollment in Phase 2 Study of RT001 in Patients with Amyotrophic Lateral Sclerosis (ALS)
Company Exceeds Target Enrollment in Less Than Six Weeks; Data Readout Expected by End of 2021LOS ALTOS, Calif., April 21,...
Silo Wellness Announces Five New Psychedelic Wellness Retreats in Jamaica
MONTEGO BAY, Jamaica, April 21, 2021 (GLOBE NEWSWIRE) -- Silo Wellness Inc. (“Silo Wellness” or “the Company”) (CSE: SILO) (FRA:3K70),...
TG Therapeutics Announces Launch of the ULTRA-V Phase 3 Trial Evaluating the Triple Combination of UKONIQ™ (umbralisib), Ublituximab, and Venetoclax
ULTRA-V Phase 2 trial has reached completion of patient enrollmentNEW YORK, April 21, 2021 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:...
Lord Jones™ Debuts “A Higher Order”
Lord Jones™ is proud to unveil its first-ever brand campaign and new website The Lord Jones campaign assets pique the imagination...
Jushi Holdings Inc. Announces a Delay in Filing 2020 Annual Financial Statements and Related Management’s Discussion and Analysis
Expects to file the 2020 Annual Financial Statements and Related Management’s Discussion and Analysis on or before May 24, 2021...
Trevena Announces TRV027 Selected for Study in Global REMAP-CAP Trial in COVID-19 Patients
-- REMAP-CAP is led by experts in pandemic response and builds upon a worldwide clinical trial network evaluating treatments for...
Embark Delta Inc. Unveils Next Generation of 2.0 Brands and Products Leveraging Proprietary Embark Nano Technology
Toronto, Ontario--(Newsfile Corp. - April 21, 2021) - Embark Delta Inc., a wholly owned subsidiary of Embark Health Inc. ("Embark"...
Immunicom Recognized as One of the Best Places to Work in the U.S.
Breakthrough Immunotherapy Company earns 2021 Great Place to Work Certification™ SAN DIEGO--(BUSINESS WIRE)--#biotech--Immunicom, Inc., a pioneering global biotechnology company, today...